http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010042163-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed48a6ebed7782c1638c388eca3b9e19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e152112649f7acfed93e380f3ca2a00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18d92c46f60af8af24e262b67381d7eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cea1185b7c717c19ffa65615bdd83611
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_335ce2bc64d696fbfa5785dc0779ac65
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
filingDate 2009-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a518e1f0811e9c73ef17d6cbfb211801
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_759a965cbd91e096568eaa351726280b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a33c873ca9918e528c4aa79b89513400
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e9f65e3417e97b90f90e4a472b06de4
publicationDate 2010-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2010042163-A3
titleOfInvention Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and sirt1, and methods of treating disorders
abstract Described herein are methods of inhibiting methionine aminopeptidase or SirT1, inhibiting angiogenesis, and treating disorders (or symptoms thereof) associated with methionine aminopeptidase, SirT1 and/or angiogenesis, wherein a compound of the invention is administered to a subject.
priorityDate 2008-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004103998-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0116108-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9619458-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0200625-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4758264-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457484072
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7047

Total number of triples: 38.